Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 4, 2003, Pages 249-253

  Haussler S ^a   Lehmann, C ^a   Breselge, C ^a   Rohde, M ^b   Classen M ^c   Tummler B ^a   Vandamme, P ^d   Steinmetz, I ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c Klinikums Links der Weser   (Germany)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA MULTIVORANS; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; HUMAN; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 18844476270     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0901-y     Document Type: Article

References (15)

1. Frangolias DD, Mahenthiralingam E, Rae S, Raboud JM, Davidson AG, Wittmann R, Wilcox PG (1999) Burkholderia cepacia in cystic fibrosis. Variable disease course. Am J Respir Crit Care Med 160:1572-1577
2. McCloskey M, McCaughan J, Redmond AO, Elborn JS (2001) Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis. Ir J Med Sci 170:28-31
3. Chaparro C, Maurer J, Gutierrez C, Krajden M, Chan C, Winton T, Keshavjee S, Scavuzzo M, Tullis E, Hutcheon M, Kesten S (2001) Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 163:43-48
4. Kanj SS, Tapson V, Davis RD, Madden J, Browning I (1997) Infections in patients with cystic fibrosis following lung transplantation. Chest 112:924-930
5. Coenye T, Mahenthiralingam E, Henry D, LiPuma JJ, Laevens S, Gillis M, Speert DP, Vandamme P (2001) Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol 51:1481-1490
6. LiPuma JJ (2001) Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis 3:149-160
7. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH (2001) Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 164:2102-2106
8. De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, Gould K, Corris PA (2001) Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358:1780-1781
9. Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E, Proctor RA, Peters G (1998) Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 177:1023-1029
10. Haussler S, Tummler B, Weissbrodt H, Rohde M, Steinmetz I (1999) Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis 29:621-625
11. Henry DA, Campbell ME, LiPuma JJ, Speert DP (1997) Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 35:614-619
12. Anwar H, Brown MR, Lambert PA (1983) Effect of nutrient depletion on sensitivity of Pseudomonas cepacia to phagocytosis and serum bactericidal activity at different temperatures. J Gen Microbiol 129 (Pt. 7):2021-2027
13. Butler SL, Nelson JW, Poxton IR, Govan JR (1994) Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol 8:285-292
14. Graves M, Robin T, Chipman AM, Wong J, Khashe S, Janda JM (1997) Four additional cases of Burkholderia gladioli infection with microbiological correlates and review. Clin Infect Dis 25:838-842
15. DeMatteo CS, Hammer MC, Baltch AL, Smith RP, Sutphen NT, Michelsen PB (1981) Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. A comparison of three methods with clinical correlations. J Lab Clin Med 98:511-518